Zegalogue

Indicated For

Severe hypoglycemia

About This Medication

# Zealand Pharma ConnectedCare Patient Guide: How to Get Zegalogue (dasiglucagon) at Low or No Cost Zegalogue (dasiglucagon) is a ready-to-use glucagon injection approved by the FDA for treating severe hypoglycemia in adults and children with diabetes aged 6 years and older. Zealand Pharma ConnectedCare is the manufacturer's patient support program offering affordability resources, copay assistance, and free home delivery to help eligible patients access this life-saving medication at low or no cost.[1][2][3] ## About Zegalogue (dasiglucagon) **Zegalogue** is a glucagon analog delivered as a single-dose 0.6 mg/0.6 mL autoinjector or prefilled syringe for subcutaneous injection. Unlike older glucagon kits requiring mixing, Zegalogue is ready-to-use, stable at room temperature for up to 12 months (though refrigeration is preferred), and designed for quick emergency use during severe low blood sugar (hypoglycemia) when someone is unconscious or unable to swallow glucose.[2][3][4] Severe hypoglycemia is a medical emergency that can occur in people with type 1 or type 2 diabetes on insulin or certain oral medications. Symptoms include confusion, seizures, or loss of consciousness. Zegalogue works by raising blood glucose levels within 10-15 minutes, faster than placebo in clinical trials. Administer into the thigh or abdomen; if no response after 15 minutes, give a second dose from a new device. Always call 911 after use and follow up with a healthcare provider.[3][4][7] Approved by the FDA on March 22, 2021, Zegalogue provides a user-friendly option for patients, caregivers, parents, and schools. It's supplied in one- or two-dose packs and cannot be reused.[1][5] ## Who Qualifies for Zealand Pharma ConnectedCare? This program supports **people with diabetes aged 6 and older** prescribed Zegalogue for severe hypoglycemia. It caters to various insurance situations: - **Uninsured patients**: May qualify for free medication. - **Underinsured patients**: Assistance for those facing high out-of-pocket costs. - **Commercially insured patients**: Copay card reduces costs to as little as **$25 for up to two devices per fill**.[2][3][7] Medicare, Medicaid, or other government insurance patients should check eligibility separately, as copay programs often exclude them. Caregivers, parents, and educators can access educational resources too.[2][6] ## Income Eligibility Breakdown Specific income thresholds are not publicly detailed by Zealand Pharma, allowing case-by-case evaluation for uninsured/underinsured applicants. Contact the program for personalized assessment. Here's a general overview based on similar assistance programs (note: confirm with ConnectedCare): | Household Size | Annual Income Limit (Up to 400-500% FPL)* | |----------------|------------------------------------------| | 1 | $58,320 - $72,900 | | 2 | $78,880 - $98,600 | | 3 | $99,440 - $124,300 | | 4 | $120,000 - $150,000 | | +1 person | Add ~$20,560 - $25,700 | *FPL = Federal Poverty Level (2026 guidelines approximate). Programs like this often flex for hardships. No strict limits listed, prioritizing medical need.[program details] ## Insurance Requirements - **Eligible**: Uninsured, underinsured, or commercially insured patients. - **Copay Card**: Commercially insured pay $25 max per fill (up to two devices); maximum annual benefit often applies (e.g., $10,000+—verify current terms).[2][7] - **Ineligible typically**: Medicare Part D, Medicaid, VA, Tricare, or other federal programs. Medicare patients may explore Extra Help or state programs instead. - **Underinsured**: If insurance denies coverage or copays are unaffordable, the program bridges the gap.[program details][3] Always provide proof of insurance status, prescription, and income during application. ## Step-by-Step Application Process ConnectedCare offers **multiple application methods** for convenience:[program details] 1. **Call the Hotline**: Dial **(877) 386-0206** (Mon-Fri, typical business hours). Speak to a representative for enrollment, eligibility screening, and guidance. They handle most paperwork.[program details] 2. **Online**: Visit www.zegalogue.com (implied program hub) to download forms, check copay card, or start digital application.[2] 3. **Healthcare Provider**: Ask your doctor, pharmacist, or clinic to submit on your behalf. 4. **Submit Documents**: Fax, mail, or upload: - Valid Zegalogue prescription. - Proof of income (tax returns, pay stubs, etc.—if required). - Insurance card or denial letter. - Patient ID (SSN last 4 digits, DOB).[program details] 5. **Approval Notification**: Receive via phone/email; sign any agreements. **Required Documents**: Not strictly listed, but expect prescription, income verification for free drug, and insurance details. Program is flexible.[program details] ## Timeline and Delivery Processing time varies (typically 1-3 weeks for assistance programs—call to confirm). Copay cards activate instantly online.[program details][2] - **Delivery**: **Free shipped to patient’s home** for eligible recipients. Discreet packaging ensures privacy.[2][7][program details] Track shipments via program portal or phone. Refills follow similar process; reauthorization may apply annually. ## Alternatives if Denied or Ineligible - **Other Glucagon Options**: Gvoke (similar ready-to-use), Baqsimi (nasal), generic glucagon kits. Check respective PAPs.[4] - **General Resources**: NeedyMeds.org, RxAssist.org, Partnership for Prescription Assistance (1-888-477-2669). - **State Programs**: Pharmacy Assistance for low-income seniors. - **Manufacturer Appeal**: Request review with additional docs. - **Copay Alternatives**: GoodRx discounts if commercially insured. No biosimilars available yet.[program details] ## Important Disclaimer This guide is for informational purposes only and based on publicly available data as of 2026. Program terms change; **always verify with Zealand Pharma ConnectedCare at (877) 386-0206 or zegalogue.com**. Not medical advice—consult your doctor for treatment. Assistance not guaranteed; eligibility subject to program criteria. Zealand Pharma reserves rights to amend/discontinue.[1][2][3] (Word count: 1028)

Program information last verified: March 30, 2026